These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 31401066)

  • 1. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
    Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C
    Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
    Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
    J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
    Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O
    J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
    Nakahata K; Uehara S; Nishikawa S; Kawatsu M; Zenitani M; Oue T; Okuyama H
    PLoS One; 2015; 10(4):e0125454. PubMed ID: 25915760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
    Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
    Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
    Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
    Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
    Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma.
    Sinha N; Panda PK; Naik PP; Maiti TK; Bhutia SK
    Tumour Biol; 2017 May; 39(5):1010428317701634. PubMed ID: 28459216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
    Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
    Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
    Yoshino J; Akiyama Y; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
    Carcinogenesis; 2020 Jul; 41(6):734-742. PubMed ID: 31665232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
    Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
    J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.
    Wang L; Wang J; Li Z; Liu Y; Jiang M; Li Y; Cao D; Zhao M; Wang F; Luo F
    Tumour Biol; 2016 Jun; 37(6):7213-27. PubMed ID: 26666817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.